Charles River Laboratories International, Inc. (CRL) vs Revvity Inc. (RVTY)
- Charles River Laboratories International, Inc. CRL 299.77 −2.11%
- Revvity Inc. RVTY 152.64 −1.34%
Charles River Laboratories International, Inc. and Revvity Inc. are both Diagnostics & Research companies. Revvity Inc. is the larger, with a market value of $17.3B against $14.6B — 1.2× the size. Charles River Laboratories International, Inc. has negative trailing earnings, so its P/E is not meaningful; Revvity Inc. trades at 72.7×. Revvity Inc. grew revenue faster over the last twelve months: 4.05% against −0.74%. Revvity Inc. has the higher net margin (8.16% vs −5.96%) and the higher return on invested capital (2.38% vs 1.07%). Across the 21 metrics below, Revvity Inc. leads on 17 and Charles River Laboratories International, Inc. on 4.
Valuation
Profitability
| Metric | CRL | RVTY | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 32.67% | 54.98% | 50.89% |
| Operating margin | 2.25% | 12.32% | (8.57%) |
| Net margin | (5.96%) | 8.16% | (6.37%) |
| Free cash flow margin | 9.27% | 19.58% | 0.00% |
| Return on equity | (7.69%) | 3.21% | (2.92%) |
| Return on assets | (3.16%) | 1.95% | (6.71%) |
| Return on invested capital | 1.07% | 2.38% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack